Northern Trust Corp Rezolute, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Rezolute, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 96,957 shares of RZLT stock, worth $414,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,957

Previous 67,182 44.32%

Holding current value

$414,975

Previous $288,000 63.19%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.13 - $5.31 $122,970 - $158,105	29,775 Added 44.32%	96,957 $470,000
Q2 2024 Aug 14, 2024	SELL	$2.29 - $5.79 $100 - $254	-44 Reduced 0.07%	67,182 $288,000
Q1 2024 May 14, 2024	SELL	$0.95 - $2.55 $15,922 - $42,738	-16,760 Reduced 19.96%	67,226 $171,000
Q4 2023 Feb 13, 2024	SELL	$0.74 - $1.24 $1,423 - $2,384	-1,923 Reduced 2.24%	83,986 $83,000
Q3 2023 Nov 13, 2023	SELL	$1.32 - $2.1 $143 - $228	-109 Reduced 0.13%	85,909 $113,000
Q2 2023 Aug 11, 2023	BUY	$1.75 - $2.33 $19,633 - $26,140	11,219 Added 15.0%	86,018 $170,000
Q1 2023 May 15, 2023	SELL	$1.79 - $2.87 $20,132 - $32,278	-11,247 Reduced 13.07%	74,799 $143,000
Q4 2022 Feb 13, 2023	SELL	$1.38 - $2.84 $510 - $1,050	-370 Reduced 0.43%	86,046 $178,000
Q3 2022 Nov 14, 2022	BUY	$2.19 - $3.49 $2,888 - $4,603	1,319 Added 1.55%	86,416 $236,000
Q2 2022 Aug 12, 2022	BUY	$2.6 - $3.85 $87,310 - $129,286	33,581 Added 65.19%	85,097 $274,000
Q1 2022 May 13, 2022	SELL	$2.27 - $5.1 $1,763 - $3,962	-777 Reduced 1.49%	51,516 $174,000
Q4 2021 Feb 08, 2022	BUY	$4.21 - $7.61 $69,018 - $124,758	16,394 Added 45.67%	52,293 $250,000
Q3 2021 Nov 15, 2021	BUY	$7.45 - $13.66 $28,123 - $51,566	3,775 Added 11.75%	35,899 $269,000
Q2 2021 Aug 13, 2021	BUY	$6.11 - $15.99 $196,277 - $513,662	32,124 New	32,124 $459,000

Others Institutions Holding RZLT

# of Institutions

Shares Held

38.5M

Call Options Held

1.6K

Put Options Held

24.6K

View Full List

About Rezolute, Inc.

Ticker RZLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,600
Market Cap $166M
Description
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...

More about RZLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Rezolute, Inc. Transaction History